TP53 and neoplasm: Cancer virotherapy is a tumor-specific strategy, in which viruses are engineered to preferentially replicate in tumor cells and destroy it by lysis, either through targeted alterations in the cancer cells such as p53 mutation, viral deletion, tissue-specific transcriptional control or tumor-specific receptors [1-3].